This is an old revision of this page, as edited by InternetArchiveBot(talk | contribs) at 06:44, 27 December 2017(Rescuing 1 sources and tagging 0 as dead. #IABot (v1.6.1)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 06:44, 27 December 2017 by InternetArchiveBot(talk | contribs)(Rescuing 1 sources and tagging 0 as dead. #IABot (v1.6.1))
Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium
9804
Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts
Not more than 300 milligrams of dihydrocodeinone (hydrocodone) per 100 milliliters or not more than 15 milligrams per dosage unit, with a fourfold or greater quantity of an isoquinoline alkaloid of opium[4]
9806
Not more than 300 milligrams of dihydrocodeinone (hydrocodone) per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active nonnarcotic ingredients in recognized therapeutic amounts[4]
9807
Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active nonnarcotic ingredients in recognized therapeutic amounts
9808
Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts
9809
Not more than 500 milligrams of opium per 100 milliliters or per 100 grams or not more than 25 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts
9810
Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts
^ ab9805 and 9806 were removed from Schedule III effective October 6, 2014, making all dihydrocodeinone-containing preparations Schedule II. See 79 FR49661.